Publications by authors named "Samar Hegazy"

Claim this Profile
L
Linking the social determinants of health and disease process using concept mapping in pre-clerkship problem-based learning courses: a pilot study.
Kellie Mullany, Barbara Masi, Jaya G Yodh, Imanni Sheppard, Grace Park, Samar A Hegazy

Acad Pathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fostering Competencies: A Scoping Review of Escape Rooms in Medical Education.
Grace L Park, Samar A Hegazy, Joseph Sepe, James Swigart, Margaret Burnette

Med Sci Educ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification.
Tarek A Bismar, Samar Hegazy, Zhaoyong Feng, Darryl Yu, Bryan Donnelly

J Cancer Res Clin Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
Tingting Wang, Hatem Abou-Ouf, Samar A Hegazy, Mohammed Alshalalfa, Konstantin Stoletov

J Mol Med (Berl)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
Adrian Box, Mohammed Alshalalfa, Samar A Hegazy, Bryan Donnelly, Tarek A Bismar

Tumour Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Amal Almami, Samar A Hegazy, Arash Nabbi, Mohammed Alshalalfa, Asma Salman

Tumour Biol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.
Ashraf Bakkar, Mohammed Alshalalfa, Lars F Petersen, Hatem Abou-Ouf, Amal Al-Mami, Samar A Hegazy

Mol Biol Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy.
Kuo-Cheng Huang, Mohammed Alshalalfa, Samar A Hegazy, Michael Dolph, Bryan Donnelly

Cancer Biol Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis.
Samir Al Bashir, Mohammed Alshalalfa, Samar A Hegazy, Michael Dolph, Bryan Donnelly

J Hematol Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma.
Samar A Hegazy, Abdulraheem Alshareef, Pascal Gelebart, Mona Anand, Hanan Armanious

Cell Signal· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic screening for synthetic lethal partners of polynucleotide kinase/phosphatase: potential for targeting SHP-1-depleted cancers.
Todd R Mereniuk, Robert A Maranchuk, Anja Schindler, Jonathan Penner-Chea, Gary K Freschauf, Samar Hegazy

Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma.
Peng Wang, Jing Dong Zhang, Fang Wu, Xiaoxia Ye, David Sharon, Samar A Hegazy

Cell Signal· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein.
Leah C Young, Kathleen M Bone, Peng Wang, Fang Wu, Benjamin A Adam, Samar Hegazy

Am J Pathol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions.
Samar A Hegazy, Peng Wang, Mona Anand, Robert J Ingham, Pascal Gelebart

J Biol Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.
Jennifer Dien Bard, Pascal Gelebart, Mona Anand, Zoulika Zak, Samar A Hegazy

Am J Pathol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis